Laser Types Compared: Q-Switched, Picosecond, and What the Difference Actually Means

A tattoo-removal laser does not remove a tattoo. It breaks the ink into fragments small enough that the body’s immune system can carry them away over the following weeks, a particle at a time. Everything else about a session, including the argument between Q-switched and picosecond devices that you will encounter on every clinic website, is a question about how efficiently a specific pulse of light breaks those fragments down.

Pulse duration is the whole fight. Nanosecond Q-switched lasers (Q-switched means the resonator is briefly held closed, then released, producing a single very short, very intense pulse) deliver energy across a few billionths of a second. Picosecond lasers deliver it across a few trillionths. That thousand-fold compression of the pulse changes the physics of what happens to the ink, and the physics shift changes how your tattoo responds: how much clears per session, how much of the tattoo ultimately fades, and how many visits the treatment course takes. Picosecond lasers do outperform Q-switched lasers on most compatible inks. The advantage is measured at the clearance endpoint, not at the session count, and it is narrower than clinic marketing implies.

What the laser is actually doing to the ink

The foundational idea is selective photothermolysis, which means targeted heating of a specific pigment with a pulse shorter than the pigment’s thermal relaxation time (how fast a particle can shed heat to surrounding tissue). Anderson and Parrish published this framework in Science in 1983, and every tattoo-removal laser since has been an application of it. Match the wavelength to the pigment. Make the pulse shorter than the pigment can cool. Destroy the pigment without cooking the skin around it.

Q-switched lasers produce nanosecond-scale pulses, typically 5 to 20 nanoseconds depending on the device (the original Anderson-Parrish work used roughly 10 ns, RevLite Q-Plus runs longer). At this timescale, the ink particle absorbs laser energy faster than heat can diffuse to surrounding tissue. The dominant fragmentation mechanism is thermal expansion, with a smaller photomechanical contribution as steam pockets form and collapse around the heated particle. The particle heats, expands, and shatters. Fragment sizes depend on ink particle size, pulse energy, and the thermal dynamics of the specific chromophore (the pigment absorbing the light). Q-switched 1064 nm Nd:YAG lasers have been clearing black ink effectively for thirty years.

Picosecond lasers compress the pulse to roughly 300 to 750 picoseconds depending on the device. At that timescale, the energy deposition is essentially instantaneous relative to thermal diffusion. The ink particle cannot dissipate heat during the pulse at all, and the dominant mechanism shifts further toward rapid pressure-wave generation. This is photoacoustic fragmentation, sometimes called photomechanical. The particle does not just heat and crack; it is essentially hit by a shockwave that breaks it into smaller pieces than the nanosecond pulse produced on the same ink.

The clinical literature comparing the two pulse regimes consistently reports better clearance with picosecond on compatible pigments, and the working mechanistic explanation is that smaller fragments are more efficiently cleared by macrophages (the immune cells that carry ink to the lymphatic system). The exact mechanistic story is still being refined; Ross and colleagues’ 1998 study in Archives of Dermatology (Ross et al. 1998), often cited for the smaller-fragment claim, actually attributed the picosecond clearance advantage primarily to changes in the optical properties of the ink, with similar particle-size distributions in both arms. Whatever the exact mechanism, the clearance difference at the patient level is real and reproducible across later studies.

A related rule of thumb in selective-photothermolysis design is that pulse duration should be shorter than the target’s thermal relaxation time, ideally well shorter, for selective destruction. Tattoo ink particles are typically 10 to 300 nanometers in diameter, putting their thermal relaxation times on the order of 0.1 to 10 nanoseconds. Nanosecond pulses sit close to the target’s cooling time. Picosecond pulses sit well below it, which is part of why fragmentation is more complete.

The mechanism shift is real. The size of the advantage it produces in your specific tattoo depends on the next question.

Wavelength is what decides which colors the laser can touch

Ink color is pigment, pigment has an absorption peak, and the laser’s wavelength has to land near that peak or the ink is effectively invisible to the light. Selective photothermolysis requires selective absorption. No absorption, no destruction, regardless of whether the pulse is nanosecond or picosecond.

The four standard wavelengths in tattoo-removal devices:

Most clinics today run multi-wavelength devices. A typical Q-switched Nd:YAG system will have 1064 and 532 nm. A typical picosecond platform often adds 755 nm in the same unit. The Candela PicoWay platform delivers native picosecond pulses at 1064, 785, 730, and 532 nm per Candela’s product literature; PicoPlus adds 595 and 660 nm dye options. Ruby (694 nm) is less common in modern clinics because alexandrite (755 nm) covers the same clinical target with more flexibility. A clinic with only 1064 nm can treat black, but cannot treat red.

This matters because your tattoo has specific colors, and only wavelengths that match those colors will do anything. A red tattoo at a clinic with only 1064 nm is a tattoo that will not fade meaningfully at that clinic. Whether the clinic’s device is pico or Q-switched is the second question. Whether the clinic’s wavelengths match your ink is the first.

Some colors resist every available wavelength, and the honest comparison has to name them upfront.

Yellow has an absorption peak in the short-wavelength blue range, roughly 440 to 510 nm. Those wavelengths exist in research devices but not in standard tattoo-removal clinical devices, because short wavelengths are heavily absorbed by epidermal melanin (the pigment that gives skin its color) before they can reach ink. A laser at 440 nm would burn the epidermis in patients with any skin pigmentation at all. The tradeoff is that yellow is substantially resistant to clearance across commercially available lasers, both Q-switched and picosecond.

White ink is essentially inert to tattoo-removal lasers. The common white pigment is titanium dioxide, which can paradoxically darken rather than fade when exposed to any Q-switched or picosecond laser. The leading explanation, discussed in the McIlwee and Alster review (McIlwee and Alster 2018), involves chemical reduction of TiO₂ to a darker oxide form during laser exposure. The darkening can be irreversible. Patients with any titanium-dioxide-containing pigment, including many cosmetic inks, should have a test patch before any treatment on any laser.

Cosmetic ink for eyebrow microblading, lip liner, and eyeliner uses iron-oxide and titanium-dioxide pigments heavily. Paradoxical darkening is a real risk on any of these, and a comparison article cannot resolve the question for your specific cosmetic ink. A test patch under a clinician’s supervision is how that question gets answered, not an internet comparison of laser types. Fluorescent, neon, and modern non-organic inks have similarly unpredictable responses across wavelengths; the clinical literature does not cover them well.

The practical framing: whether a clinic’s device has the wavelength your tattoo needs is more important than whether that device is picosecond or Q-switched. A well-operated Q-switched 1064-plus-532 nm clinic can treat a black-and-red tattoo. A picosecond 1064-plus-755 nm clinic cannot treat red as directly as a 532 nm device would, even though the picosecond system is the more expensive piece of equipment.

The clearance question, grounded in the peer-reviewed literature

This is the section that probably made you click. The clinic-marketing version of the answer says picosecond clears tattoos in half the sessions. The peer-reviewed version says something more specific and less dramatic, and it measures a different thing.

The defensible claim, grounded in the comparative literature, is this: picosecond lasers clear a larger proportion of compatible tattoos to the same endpoint as nanosecond Q-switched lasers at comparable session counts, with wide variance by ink color, skin phototype, and operator technique.

The quantitative anchors in that literature:

• Lorgeou and colleagues’ 2018 prospective randomized study in the Journal of the European Academy of Dermatology and Venereology (Lorgeou et al. 2018) compared two picosecond lasers to one nanosecond laser on 49 patients with primarily black and dark-blue tattoos. Across a fixed course of treatment, 33% of picosecond-treated tattoos reached at least 75% color-intensity reduction, compared to 14% of nanosecond-treated tattoos (P = 0.008). This is a doubling of the proportion of tattoos hitting a clinically meaningful clearance endpoint at the same number of sessions.

• Kono and colleagues’ 2020 prospective comparison study in Laser Therapy (Kono et al. 2020) split 37 professional tattoos across 11 Asian patients between picosecond and nanosecond arms at 532 and 1064 nm. The picosecond arms were significantly more effective on black ink at 1064 nm and on red and green inks at 532 nm. Post-inflammatory hyperpigmentation rates ranged from roughly 22% to 35% depending on arm, and paradoxical darkening occurred in 5.4% of cases overall across all arms.

• Wu and colleagues’ 2025 meta-analysis in Lasers in Medical Science (Wu et al. 2025) pooled 20 randomized controlled trials plus one retrospective comparative study, for 971 patients total, across picosecond and nanosecond treatment of both hyperpigmented disorders and tattoos. For tattoos specifically, the relative risk of reaching at least 75% clearance with picosecond was 1.39 compared to nanosecond (95% CI 0.99 to 1.94, P = 0.05). For endogenous pigmentation (melasma, nevus of Ota, and related conditions), the clearance rates were comparable between the two laser types.

What these three anchors support together: on compatible inks, a given course of picosecond treatment is roughly 30% to 40% more likely to hit the 75% clearance endpoint than a matched course of nanosecond treatment. Over the full treatment arc, that can translate into modestly fewer total sessions to reach a target fade level, but the literature does not support a precise “fewer sessions” multiplier and the advantage varies widely by patient and ink. Reddit reports of half-session-count reductions on specific tattoos happen; so do reports of no difference at all. Both are real.

The variance is not evenly distributed. The picosecond advantage is largest on multicolored tattoos, especially those containing greens, dark blues, or recalcitrant reds. It is substantial on solid black and dark blue tattoos in Fitzpatrick I to III patients. It narrows on solid-black tattoos that respond well to 1064 nm nanosecond treatment, where the Q-switched laser was already doing a reasonable job. It approaches zero on resistant inks (yellow, white, cosmetic ink), where neither laser reliably clears the pigment.

Some consumer articles apply the Kirby-Desai score, a six-factor predictor proposed by Kirby and colleagues in 2009 for nanosecond Q-switched session-count estimation (Kirby et al. 2009, Journal of Clinical and Aesthetic Dermatology 2(3):32 to 37), with a simple multiplier such as KD × 0.7 to produce a “picosecond-corrected” number. The peer-reviewed primary literature does not support a single universal multiplier. The picosecond advantage varies patient to patient and ink to ink far more than a flat discount captures. When Kirby-Desai appears at a consultation, treat the resulting number as a structured estimate refined by clinical assessment, not as an arithmetic prediction of your outcome.

The practical implication for an anxious first-timer: expect a range, not a number. A clinician telling you “you will need X sessions” is offering an estimate with variance. Fitzpatrick type, ink color, ink density, tattoo age, and the operator’s settings and technique shift that estimate more in most cases than the pico-versus-nanosecond choice does. The choice between platforms is one variable among several.

Pain: a picosecond advantage on average, with cooling doing most of the work

Clinical reports describe picosecond sessions as less painful than comparable Q-switched sessions. The magnitude is real but modest, and the dominant variable in what the patient feels is cooling, not pulse duration.

Most modern clinics on either platform use a forced cold-air cooling system that blows approximately -30°C air at the treatment area during the session. Topical lidocaine cream (a numbing cream applied at least 60 minutes before the session) is the standard first-line pain control on either platform. Injectable lidocaine (local anesthesia injected at the site by a medical professional) reduces pain substantially per Astanza’s practitioner-facing documentation and is available only at clinics with a medical professional on site. These cooling and anesthesia layers determine most of what the patient actually feels.

Bäumler and colleagues’ 2022 prospective split-study in the Journal of the European Academy of Dermatology and Venereology (Bäumler et al. 2022) split 30 tattoos across 23 subjects between a nanosecond laser at 694 nm and picosecond lasers at 532 and 1064 nm. The study found patient-reported pain meaningfully lower on the picosecond arms than on the nanosecond arm, with the difference reaching statistical significance. The reported magnitude of the gap was modest, roughly one unit on a ten-point scale, in a study where both arms received comparable cooling and anesthesia.

The useful frame: pain in a tattoo-removal session is shaped by cooling, topical anesthesia, operator fluence (energy delivered per unit area), and pulse duration, roughly in that order of impact. Picosecond contributes a consistent advantage of about one pain-scale unit on average. A well-cooled, well-numbed Q-switched session on a compatible tattoo is tolerable for most patients. Patients describe the sensation, on either platform, as a snapping rubber band. Some describe it as hot pin pricks. First sessions tend to hurt more than later ones, on either platform, because ink density is highest at the start.

If pain is your top concern, ask what cooling protocol the clinic uses and what topical or injectable anesthesia options are available. Those questions will tell you more about what your session will feel like than “is the laser pico.”

Cost: picosecond runs higher per session; total-cost math depends on variables nobody can predict in advance

A new, full-configuration picosecond device from a major manufacturer runs roughly $250,000 to $500,000 in acquisition cost depending on model and configuration. New Q-switched Nd:YAG platforms cost roughly half that, and the used-device market for both can be considerably lower. The per-session pricing at picosecond-equipped clinics typically runs higher than per-session pricing at Q-switched independents, though published numbers vary by clinic, market, and tattoo size.

The total-cost comparison between platforms depends on three things no comparison can know in advance for your specific tattoo: how many sessions each platform needs to reach your target fade level, the specific per-session price at each clinic you are considering, and whether one platform gets you to a clearance endpoint the other would not reach at all on your specific ink. On compatible inks, the higher per-session price of the picosecond clinic is partially offset by the higher clearance efficiency per session; sometimes the total lands lower on picosecond, sometimes lower on Q-switched, sometimes it is close to a wash. On resistant inks, the platform difference is close to moot because neither will reliably clear the pigment.

Specific dollar figures, if quoted here, would be dated and tied to one clinic’s public pricing page. Published per-session prices drift silently, chains restructure pricing quarterly, and per-session prices at picosecond clinics range widely by tattoo size and body location. The structural comparison that survives the drift: ask for a total-cost estimate across the estimated session range, not the per-session sticker price, and compare total out-of-pocket across platforms for your specific tattoo.

Chains and many independents offer financing packages. Financing pricing is often presented in monthly payment terms, for example $89 or $125 per month over 24 or 36 months. These numbers obscure total cost. A $125 monthly payment over 24 months is $3,000 total before any interest, not a $125 service. A reader comparing platforms should calculate total out-of-pocket across the full session arc on each platform and compare those totals, not the monthly numbers. The site’s own tattoo-removal cost calculator produces a structured total-cost estimate from the inputs that move the math most.

The questions that matter at consultation: how many sessions does the clinician estimate for your specific tattoo and skin type, what is the full per-session price, what is the policy if treatment extends beyond the estimate, and what is the refund or credit mechanism if you move or stop mid-course. Compare those answers, not the marketing headline.

What the major chains use

The two largest US tattoo-removal chains publish their equipment or have it disclosed on primary sources a reader can check.

Removery uses the Candela PicoWay platform exclusively, per Removery’s own technology page at removery.com. The PicoWay is a picosecond Nd:YAG system delivering native picosecond pulses at 1064, 785, 730, and 532 nm per Candela’s product literature, which covers black and dark-blue inks at 1064 nm, resistant greens and blues at 785 and 730 nm, and reds and oranges at 532 nm. Removery’s own page describes the platform as having “three different wavelengths” in clinical use across their network.

LaserAway uses the Astanza Duality, per manufacturer disclosure in the Astanza Laser case study. The Astanza Duality is a Q-switched Nd:YAG system at 1064 and 532 nm. Chain equipment can change over time, and individual locations may have additional devices; the device a clinic actually treats with on a given day is a question to confirm at consultation.

Smaller chains and independent clinics vary widely. Astanza Trinity is a common multi-wavelength Q-switched Nd:YAG at smaller chains and independent practices. Dermatology offices and laser-focused medspas often have PicoPlus, Enlighten III, Discovery Pico, or RevLite Q-Plus. Chain-to-chain device variation is broader than chain-to-chain pricing variation.

A few reader-side identification moves are available. Asking by model name in consultation gets a model-name answer, not a generation. Acceptable answers include PicoWay, PicoSure, PicoPlus, Enlighten III, Discovery Pico, RevLite Q-Plus, Astanza Trinity, Astanza Duality, Quanta Q-Plus. A clinic that cannot name its device clearly, or that responds with “the latest picosecond technology” without specifying the model, is worth a follow-up question.

Most clinics publish their equipment on an “Our Technology,” “About Our Laser,” or similar page. If the page names only “state-of-the-art picosecond laser” without a model, that is a signal to ask in the consultation.

The model name, once you have it, can be cross-referenced on the FDA 510(k) database at fda.gov (the FDA’s public premarket-clearance registry for medical devices). Every laser legally marketed for tattoo removal in the United States has a public 510(k) clearance record naming the device, manufacturer, cleared wavelengths, pulse durations, and cleared indications. Searching the device name returns the authoritative spec sheet, which is the step clinic marketing pages do not take and the step that tells you what the device actually is rather than how it is branded.

None of this ranks clinics. It identifies what the clinic is working with, which is a different question from whether the clinic is the right choice for your tattoo. The ranking-side question lives in how to choose a tattoo-removal clinic.

When the picosecond-vs-Q-switched distinction actually matters

For some tattoos, the choice between platforms is consequential. For others, it is closer to a wash, and the more important variables live elsewhere.

The distinction matters meaningfully on multicolored tattoos containing greens, dark blues, or recalcitrant reds, which benefit from the picosecond advantage at the relevant wavelengths. It matters on large tattoos, where clearance-efficiency differences multiply across many sessions and shift total cost and total time materially. It matters for patients who strongly prefer hitting a clearance endpoint with higher per-session efficiency and are willing to pay the per-session premium to get there. And it matters on tattoos with unusual pigment mixes that prior Q-switched treatment has not cleared, where the picosecond mechanism’s smaller fragment size may produce clearance the nanosecond pulse did not.

The distinction is overplayed by marketing on solid-black tattoos in Fitzpatrick I to III patients, where Q-switched 1064 nm Nd:YAG clears ink efficiently and the between-platform delta is narrower than clinic websites suggest. It is overplayed on small tattoos, where the absolute difference in session count is a handful of visits at most. It is overplayed for patients on a tight budget, where total-cost math may favor the Q-switched option once the per-session premium is accounted for. And it is overplayed for patients whose nearest Q-switched clinic has an experienced operator and whose nearest picosecond clinic does not.

Some things do not change across platforms. Yellow, white, and cosmetic ink remain resistant regardless of laser generation. Paradoxical darkening of titanium-dioxide-containing pigments is a possibility on both. Fitzpatrick V to VI patients carry higher post-inflammatory hyperpigmentation risk on either platform, managed with lower fluences and longer intervals on either; the scarring guide covers what those risks look like in practice. Session spacing of 6 to 8 weeks minimum applies to both, because the limiting factor is the immune system’s pigment-clearance cycle, not the laser pulse duration.

A patient with a tattoo containing yellow, white, or cosmetic ink should understand that a portion of the tattoo may remain visible after a full treatment course on any available laser. This is not a failure of the clinic or the platform. It is the bound of what current technology reliably achieves. No honest comparison of Q-switched and picosecond lasers can omit that bound.

The largest variable in your outcome, on either platform, is operator skill: the clinician’s training, their fluence selection and adjustment across the treatment course, whether they use appropriate cooling, how they handle your specific Fitzpatrick type and ink color combination, and how they structure the consultation. A well-trained operator on a Q-switched 1064 nm Nd:YAG will outperform a poorly trained operator on the newest picosecond device on most patients. Platform matters. Operator matters more.

What to ask at your consultation

The platform choice for your specific tattoo is a question a clinician examining it in person will answer better than any comparison article can. Four questions worth bringing:

What specific device do you use? The answer should be a model name, not a generation.

Which wavelengths does your device emit? This matters if your tattoo has colors beyond black and dark blue.

How many sessions do you estimate for my tattoo and my skin type, and what is the variance in that estimate? The answer should be a range, not a point. If the clinician quotes a single number, that is a signal to ask about the variance.

What is your fluence selection and adjustment process across the treatment course, and what cooling protocol do you use during sessions? Fluence and cooling drive outcomes and pain more than platform choice.

Some clinics apply the Kirby-Desai scale during consultation to estimate session count. The scale adds points across six factors (skin type, ink color, location, layering, scarring, and ink density) and produces a range. The original 2009 paper was written for nanosecond Q-switched treatment, and picosecond adjustments to the score remain patient-specific rather than captured by a universal multiplier. When you see a Kirby-Desai estimate at consultation, it is a structured estimate refined by clinical assessment, not a prediction of your specific outcome. The site’s own calculator produces a similar structured estimate from factors you can self-assess. Neither is a quote.

The argument between picosecond and Q-switched is a question about fragmentation efficiency on specific ink colors in specific patients. Your question is simpler: which clinic can examine your tattoo honestly and treat it competently. The laser is one piece of that answer.